Wells Fargo’s Anebulo Pharmaceuticals ANEB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-62
| Closed | -$178 | – | 6500 |
|
|
2024
Q1 | $178 | Buy |
62
+1
| +2% | +$3 | ﹤0.01% | 6125 |
|
|
2023
Q4 | $148 | Buy |
61
+3
| +5% | +$7 | ﹤0.01% | 6230 |
|
|
2023
Q3 | $177 | Buy |
58
+1
| +2% | +$3 | ﹤0.01% | 6242 |
|
|
2023
Q2 | $134 | Buy |
57
+2
| +4% | +$5 | ﹤0.01% | 6499 |
|
|
2023
Q1 | $160 | Buy |
55
+1
| +2% | +$3 | ﹤0.01% | 6510 |
|
|
2022
Q4 | $131 | Buy |
54
+17
| +46% | +$41 | ﹤0.01% | 6405 |
|
|
2022
Q3 | $0 | Buy |
37
+17
| +85% | – | ﹤0.01% | 6280 |
|
|
2022
Q2 | $0 | Buy |
20
+1
| +5% | – | ﹤0.01% | 6453 |
|
|
2022
Q1 | $0 | Hold |
19
| – | – | ﹤0.01% | 6627 |
|
|
2021
Q4 | $0 | Hold |
19
| – | – | ﹤0.01% | 6618 |
|
|
2021
Q3 | $0 | Hold |
19
| – | – | ﹤0.01% | 6594 |
|
|
2021
Q2 | $0 | Buy |
+19
| New | – | ﹤0.01% | 6515 |
|